Trevi Therapeutics Inc

Small-Cap Stocks Pharmaceutical Stocks Healthcare Stocks

$11.44

+0.80 (+7.52%)

As of Mar 25, 10:01 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 17 94%

Hold 1 6%

Sell 0 0%

Price Target

Analyst Price Target +91.7% upside

Low Target $18.04

Average Target $21.93

High Target $33.12

Current Price $11.44

Current
$11.44

Target
$21.93

$18.04 $21.93 avg $33.12

Scenario Analysis

Bear Case

$18.04

57.7%

Low target

Base Case

$21.93

+91.7%

Avg target

Bull Case

$33.12

+189.5%

High target

Risk/Reward

3.3x

Highly favorable

Price in Context

52-Week High

$14.39

-20.5% from high

52-Week Low

$4.85

+135.9% from low

Target vs 52W High

$21.93

+52.4% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	39	77%	$1,330.33	+45.2%
JNJ Johnson & Johnson	Buy	32	59%	$299.55	+24.8%
MRK Merck & Co. Inc.	Buy	36	67%	$159.27	+33.4%
PFE Pfizer Inc.	Hold	35	40%	$33.90	+24.3%
BMY Bristol-Myers Squibb Co	Hold	36	42%	$174.50	+196.1%
ZTS Zoetis Inc	Buy	25	64%	$209.87	+79.8%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-22.9%
VTRS Viatris Inc	Buy	18	67%	$122.82	+809.8%